No Such Thing as a Safe Cigarette
Despite their marketing as a "healthier" option, so-called "light" filtered cigarettes may actually be causing more cases of a certain type of lung cancer, a new study found.
Lung Cancer Gets New Treatment
The US Food and Drug Administration (FDA) has approved a new medication to treat non-small cell lung cancer.
Tecentriq Gets a New Job
The US Food and Drug Administration has approved Tecentriq (atezolizumab) to treat advanced lung cancer.
Plus One for Lung Cancer Surgery
Surgery for patients with late-stage, non-small cell lung cancer (NSCLC) may increase survival, but many patients aren't having the procedure, a new study found.
Good News for Older Patients with Lung Cancer
Post-surgery survival rates for older patients with lung cancer may be improving, a new study found.
A New Job for Gilotrif
The US Food and Drug Administration has approved Gilotrif (afatinib) to treat squamous cell lung cancer.
A New Job for Xalkori
The US Food and Drug Administration (FDA) approved Xalkori (crizotinib) to treat patients with advanced non-small cell lung cancer (NSCLC) who have tumors with an ROS-1 gene alteration.
Is a PET Scan the Right Option for You?
For cancer survivors, vigilance is a key part of remaining cancer free. But new evidence suggests one cancer detection tool is being overused — and that isn’t helping anyone.
Cancer Meds in 2015: A Year in Review
This year was a big one for cancer treatment.
A New Option for ALK-Positive Lung Cancer
The U.S. Food and Drug Administration today approved Alecensa (alectinib) to treat people with advanced (metastatic) ALK-positive non-small cell lung cancer (NSCLC) whose disease has worsened after, or who could not tolerate treatment with, another therapy called Xalkori (crizotinib).